{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:34:04Z","timestamp":1787841244045,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Thyroid papillary carcinoma (PTC) is the most common carcinoma of thyroid carcinomas and endocrine carcinomas. The diagnosis of thyroid PTC is made mainly by the presence of nuclear features such as nuclear clearing, groove, and nuclear inclusions. Some benign lesions of the thyroid may have nuclear features and growth patterns of papillary thyroid carcinomas, which can make the differential diagnosis difficult. Different immunohistochemical markers have always been needed to reduce diagnostic errors and detect malignancies in routine practice. As in all tumor cases, studies continue to understand carcinogenesis in thyroid carcinomas. One of the ways that can help understand this involves the use of new and effective immunohistochemical markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to examine the expression of epithelial cell adhesion molecule (EpCAM), Galectin-3 (Gal-3), and proliferative cell nuclear antigen (PCNA), which are immunohistochemical markers that may contribute to the diagnosis and prognosis of thyroid PTCs and lymph node (LN) metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>EpCAM, Gal-3, and PCNA immunohistochemical markers were applied to 26 unifocal (UF) thyroid PTC cases and 25 thyroid PTC cases with LN metastasis or multifocal (MF) tumor field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>It was observed that the Gal-3 staining score decreased significantly in the LN metastasis focus compared to the UF tumor. With EpCAM significant loss of membranous expression was observed in the MF tumor compared to the UF tumor. There was no statistically significant difference between the case groups in terms of PCNA staining score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These results may be important in terms of obtaining new immunohistochemical clues for diagnosis and carcinogenesis in thyroid PTCs and their metastases. The number of cases in our study is limited, and we think that supporting the results with a large series of studies may contribute to the diagnosis and prognosis of the patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_346_24","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:00:30Z","timestamp":1774926030000},"page":"350-355","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Epithelial Cell Adhesion Molecule, Galectin-3, and Proliferative Cell Nuclear Antigen Expression in Thyroid Papillary Carcinomas and Their Lymph Node Metastases"],"prefix":"10.4103","volume":"29","author":[{"given":"F","family":"Daltaban","sequence":"first","affiliation":[{"name":"Department of Pathology, G\u00fcm\u00fc\u015fhane Government Hospital, G\u00fcm\u00fc\u015fhane, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Sayar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tayfur","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"G\u00fcrb\u00fczel","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MG","family":"Balc\u0131","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"R2-20260416","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"R3-20260416","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/modpathol.2008.10","article-title":"Thyroid carcinoma: Molecular pathways and therapeutic targets","volume":"21","author":"Nikiforov","year":"2008","journal-title":"Mod Pathol"},{"key":"R4-20260416","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2217\/fon.10.127","article-title":"Thyroid cancer gender disparity","volume":"6","author":"Rahbari","year":"2010","journal-title":"Future Oncol"},{"key":"R6-20260416","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"key":"R7-20260416","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ctrv.2011.04.002","article-title":"Epithelial cell adhesion molecule expression (CD326) in cancer: A short review","volume":"38","author":"Patriarca","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"R8-20260416","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2353\/ajpath.2007.070152","article-title":"Epithelial cell adhesion molecule: More than a carcinoma marker and adhesion molecule","volume":"171","author":"Trzpis","year":"2007","journal-title":"Am J Pathol"},{"key":"R9-20260416","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1158\/0008-5472.CAN-09-0654","article-title":"The emerging role of EpCAM in cancer and stem cell signaling","volume":"69","author":"Munz","year":"2009","journal-title":"Cancer Res"},{"key":"R10-20260416","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","article-title":"Galectin-3\u2013a jack-of-all-trades in cancer","volume":"313","author":"Newlaczyl","year":"2011","journal-title":"Cancer Lett"},{"key":"R11-20260416","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2014.01.019","article-title":"Galectin-3 in cancer","volume":"431","author":"Song","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R12-20260416","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrm3562","article-title":"Regulation of PCNA\u2013protein interactions for genome stability","volume":"14","author":"Mailand","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R13-20260416","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2014.02.004","article-title":"PCNA: A silent housekeeper or a potential therapeutic target?","volume":"35","author":"Wang","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"R14-20260416","first-page":"1378","article-title":"Correlations of PCNA expression with thyroid cancer ultrasound and histopathologic features","volume":"12","author":"Yang","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"R15-20260416","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2407-10-331","article-title":"EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis","volume":"10","author":"Ralhan","year":"2010","journal-title":"BMC Cancer"},{"key":"R16-20260416","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/0300060513490617","article-title":"Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: Improvement in the sensitivity or specificity?","volume":"41","author":"Wu","year":"2013","journal-title":"J Int Med Res"},{"key":"R17-20260416","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4318\/tjg.2013.0571","article-title":"Expression and significance of IGF-2, PCNA, MMP\u20137 and \u03b1-actin in gastric carcinoma with Lauren classification","volume":"24","author":"Kuang","year":"2013","journal-title":"Turk J Gastroenterol"},{"key":"R18-20260416","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4081\/ejh.2009.e8","article-title":"Changes in the balance between proliferation and apoptosis during the progression of malignancy in thyroid tumours","volume":"53","author":"Cvejic","year":"2009","journal-title":"Eur J Histochem"},{"key":"R19-20260416","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","article-title":"Expression and function of epithelial cell adhesion molecule EpCAM: Where are we after 40 years?","volume":"39","author":"Gires","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"R20-20260416","doi-asserted-by":"crossref","first-page":"e42893","DOI":"10.1371\/journal.pone.0042893","article-title":"An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma","volume":"7","author":"He","year":"2012","journal-title":"PLoS One"},{"key":"R21-20260416","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2407-12-523","article-title":"Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma","volume":"12","author":"Kunavisarut","year":"2012","journal-title":"BMC Cancer"},{"key":"R22-20260416","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5505\/kjms.2020.59862","article-title":"Cytokeratin-19 and Galectin-3 Expression in Benign and Malignant Epithelial Tumors and Nonneoplastic Lesions of Thyroid","volume":"10","author":"Balc\u0131","year":"2020","journal-title":"Kafkas J Med Sci"},{"key":"R23-20260416","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/hp.2000.6534","article-title":"Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation","volume":"31","author":"Kawachi","year":"2000","journal-title":"Hum Pathol"},{"key":"R24-20260416","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12022-008-9033-3","article-title":"Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma","volume":"19","author":"Turkoz","year":"2008","journal-title":"Endocr Pathol"},{"key":"R25-20260416","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1568009620666200115162814","article-title":"Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation","volume":"20","author":"Cardano","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"key":"R26-20260416","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01218417","article-title":"Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma","volume":"119","author":"Skopelitou","year":"1993","journal-title":"J Cancer Res Clin Oncol"},{"key":"R27-20260416","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1309\/LF3Q1NQKMT2N9KNV","article-title":"Coexistent anaplastic and differentiated thyroid carcinoma: An immunohistochemical study","volume":"125","author":"Aratake","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R28-20260416","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/1097-0142(19930501)71:9<2807::AID-CNCR2820710920>3.0.CO;2-5","article-title":"Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen\/cyclin immunohistochemical studies","volume":"71","author":"Shimizu","year":"1993","journal-title":"Cancer"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_346_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:47:21Z","timestamp":1787838441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_346_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_346_24","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2024-05-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}